Thyrocare Technologies Limited — Board Meeting, 23-10-2024: Outcome of Board Meeting

Thyrocare Technologies Limited held a board meeting, during which it approved the unaudited financial results for the quarter and half-year ended September 30, 2024. Additionally, the board approved the allotment of 19,727 equity shares under the ESOS 2021, increasing the paid-up equity capital to 52,972,403 shares. The financial results and related reports are available on the company's website and will be published in local newspapers.